1. The Role of p90 Ribosomal S6 Kinase (RSK) in Tyrosine Kinase Inhibitor (TKI)-Induced Cardiotoxicity
    Muna Suleiman et al, 2024, Journal of Cardiovascular Translational Research CrossRef
  2. Screening of break point cluster region Abelson tyrosine kinase inhibitors by capillary electrophoresis
    Mei Xu et al, 2018, Journal of Chromatography A CrossRef
  3. Celery
    Phetcharat Boonruamkaew et al, 2020, Nutritional Composition and Antioxidant Properties of Fruits and Vegetables CrossRef
  4. RETRACTED: Luteolin retards CXCL12-induced Jurkat cells migration by disrupting transcription of CXCR4
    Yunwen Bu et al, 2020, Experimental and Molecular Pathology CrossRef
  5. Bioactive Compounds from Curcuma amada and Their Effect on Acute Myeloid Leukemia
    Ajila Chandran et al, 2022, Critical Reviews™ in Oncogenesis CrossRef
  6. Recent Advances in Natural Products with Anti-Leukemia and Anti- Lymphoma Activities
    Zhi-Gang Sun et al, 2024, Mini-Reviews in Medicinal Chemistry CrossRef
  7. Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2
    Li Wang et al, 2019, Phytotherapy Research CrossRef
  8. Flavonols and Flavones as Potential anti-Inflammatory, Antioxidant, and Antibacterial Compounds
    Maria do Socorro S. Chagas et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
  9. Therapeutic effects of Sheng Xue Fang in a cyclophosphamide-induced anaemia mouse model
    Lu Dou et al, 2021, Pharmaceutical Biology CrossRef
  10. Modulation of drug resistance in leukemia using phytochemicals: an in-silico, in-vitro, and in-vivo approach
    Urja Desai et al, 2023, Recent Frontiers of Phytochemicals CrossRef
  11. Response of Myeloid Leukemia Cells to Luteolin is Modulated by Differentially Expressed Pituitary Tumor-Transforming Gene 1 (PTTG1) Oncoprotein
    Pei-Yi Chen et al, 2018, International Journal of Molecular Sciences CrossRef
  12. Stimulation of Fas/FasL‐mediated apoptosis by luteolin through enhancement of histone H3 acetylation and c‐Jun activation in HL‐60 leukemia cells
    Shih‐Wei Wang et al, 2018, Molecular Carcinogenesis CrossRef
  13. Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development
    Debasis Patnaik et al, 2018, Oncotarget CrossRef
  14. The Anti-Leukemic Activity of Natural Compounds
    Coralia Cotoraci et al, 2021, Molecules CrossRef
  15. Efficacy of the plantago major L. syrup on radiation induced oral mucositis in head and neck cancer patients: A randomized, double blind, placebo-controlled clinical trial
    Gholamreza Mohammad Soltani et al, 2020, Complementary Therapies in Medicine CrossRef
  16. Unraveling the therapeutic potential of natural products in the prevention and treatment of leukemia
    Harsh Goel et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  17. Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics
    Kun Han et al, 2018, Scientific Reports CrossRef
  18. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses
    Li Li et al, 2019, Phytomedicine CrossRef
  19. Flavonoids as Potential Anticancer Agents in Clinics: Where Have We Reached So Far?
    Balbir Singh et al, 2019, Current Aspects of Flavonoids: Their Role in Cancer Treatment CrossRef
  20. Luteolin induces myelodysplastic syndrome‑derived cell apoptosis via the p53‑dependent mitochondrial signaling pathway mediated by reactive oxygen species
    Weimin Dong et al, 2018, International Journal of Molecular Medicine CrossRef
  21. RSK inhibitors as potential anticancer agents: Discovery, optimization, and challenges
    Ying Sun et al, 2023, European Journal of Medicinal Chemistry CrossRef
  22. Luteolin inhibits melanoma growth in vitro and in vivo via regulating ECM and oncogenic pathways but not ROS
    John Schomberg et al, 2020, Biochemical Pharmacology CrossRef
  23. Natural Product Luteolin Rescues THAP-Induced Pancreatic β-Cell Dysfunction through HNF4α Pathway
    Wenyu Wu et al, 2020, The American Journal of Chinese Medicine CrossRef